Paolo Calabria

Showing 1-2 of 2 articles

Coronary interventions

One-year clinical results of the Italian diffuse/multivessel disease ABSORB prospective registry (IT-DISAPPEARS)

Testa L, De Carlo M, Petrolini A, Rapetto C, Varbella F, Cortese B, Gabrielli G, Geraci S, Loi B, Boccuzzi G, Tarantini G, Fischetti D, Calabria P, Tomai F, Ribichini F, Tamburino C, Indolfi C, Bartorelli A, Petronio A, Bedogni F

July 20, 2017 | 10.4244/EIJ-D-17-00246

One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE)

Tamburino C, Capodanno D, Erglis A, Menown I, Horvath I, Moreno R, Gilbert T, Crowley J, Calabria P, Allocco D, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_01

1

Latest news

CTOs, next-day discharge after TAVI, ViV, cerebral embolic protection, TMVR

Ahead of Print: Coronary Artery Thrombosis in COVID-19

Coronary collaterals, the natural grafts of CTO lesions

TWILIGHT, ONYX ONE, DKCRUSH-V and much more

(The Trials book is supported by Biotronik)

August 11, 2020

Guidance Papers

Guidelines, consensus & position papers

Intravascular ultrasound in PCI for in-stent CTO: guidance for long-term success

JM De la Torre Hernandez

This Week's JAA's: Real-world Use of the Evolut PRO Valve...

Valvular disease